免疫检查点抑制剂治疗恶性肿瘤的PET/CT 评价专家共识(2020 版).
李思进， 吴宁 - Chinese Journal of Oncology, 2020 - search.ebscohost.com
免疫检查点抑制剂(ICIs) 是恶性肿瘤治疗领域的重大突破, 但由于其作用机制使然,
出现了假性进展, 超进展等特殊肿瘤应答模式, 对临床治疗决策和疗效评价带来了困难与挑战 …
出现了假性进展, 超进展等特殊肿瘤应答模式, 对临床治疗决策和疗效评价带来了困难与挑战 …
Expert consensus on assessing tumor response to immune checkpoint inhibitors by PET/CT (2020 Edition)
PET Group - Zhonghua zhong liu za zhi [Chinese …, 2020 - pubmed.ncbi.nlm.nih.gov
The Immune checkpoint inhibitors (ICIs) have represented a major breakthrough in the field
of malignant tumor treatment. However, due to the mechanism of this novel therapy, some …
of malignant tumor treatment. However, due to the mechanism of this novel therapy, some …
[引用][C] 18 F-FDG PET/CT和新型分子成像在指导肿瘤免疫治疗中的作用
王栋梁， 许晓平， 宋少莉 - 肿瘤影像学, 2023 - zhongliuyingxiangxue.com
免疫治疗是以自身免疫系统为基石的抗肿瘤反应, 已经改变了许多癌症的治疗格局,
但免疫检查点抑制剂(immune checkpoint inhibitor, ICI) 作用机制复杂, 肿瘤患者常出现延迟 …
但免疫检查点抑制剂(immune checkpoint inhibitor, ICI) 作用机制复杂, 肿瘤患者常出现延迟 …
Conventional Radiological Techniques and PET-CT in Treatment Response Evaluation in Immunotherapy Settings
A Castello, E Lopci - Atlas of Clinical PET-CT in Treatment Response …, 2021 - Springer
The introduction of targeted therapies and, mostly, immune checkpoint inhibitors (ICI) has
positively revolutionized the scenario of cancer treatment. In this chapter, we provide an …
positively revolutionized the scenario of cancer treatment. In this chapter, we provide an …
[HTML][HTML] Impact of PET/CT for assessing response to immunotherapy—A clinical perspective
D Lang, G Wahl, N Poier, S Graf, D Kiesl… - Journal of Clinical …, 2020 - mdpi.com
Cancer immunotherapy using immune-checkpoint inhibitors (ICI) has revolutionized the
therapeutic landscape of various malignancies like non-small-cell lung cancer or melanoma …
therapeutic landscape of various malignancies like non-small-cell lung cancer or melanoma …
[HTML][HTML] Evaluation of response to immune checkpoint inhibitors: is there a role for positron emission tomography?
M Bauckneht, R Piva, G Sambuceti… - World Journal of …, 2017 - ncbi.nlm.nih.gov
Strategies targeting intracellular negative regulators such as immune checkpoint inhibitors
(ICPIs) have demonstrated significant antitumor activity across a wide range of solid tumors …
(ICPIs) have demonstrated significant antitumor activity across a wide range of solid tumors …
Predicting response to immunotherapy by evaluating tumors, lymphoid cell-rich organs, and immune-related adverse events using FDG-PET/CT
T Nobashi, L Baratto, SA Reddy, S Srinivas… - Clinical nuclear …, 2019 - journals.lww.com
Purpose To investigate whether the evaluation of tumors, lymphoid cell-rich organs, and
immune-related adverse events (IRAE) with 18 F-FDG PET/CT can predict the efficacy and …
immune-related adverse events (IRAE) with 18 F-FDG PET/CT can predict the efficacy and …
[HTML][HTML] Meditating on Cancer Management at the Time of Immunotherapy
E Lopci - Journal of Clinical Medicine, 2022 - mdpi.com
The introduction of checkpoint inhibitors in the last decade has prompted a new era in
medical oncology and has opened the door to novel frontiers in cancer treatment …
medical oncology and has opened the door to novel frontiers in cancer treatment …
[PDF][PDF] PET/CT 在非小细胞肺癌免疫治疗效果评价中的应用及进展
李林蔚， 杨健， 陈跃 - 肿瘤影像学, 2023 - zhongliuyingxiangxue.com
肿瘤免疫治疗, 尤其是免疫检查点抑制剂(immune checkpoint inhibitor, ICI)
的出现为晚期非小细胞肺癌的治疗提供了新思路. 精准地评价治疗效果能指导临床决策 …
的出现为晚期非小细胞肺癌的治疗提供了新思路. 精准地评价治疗效果能指导临床决策 …
[HTML][HTML] Evaluating response to immunotherapy with 18F-FDG PET/CT: where do we stand?
N Aide, M De Pontdeville, E Lopci - European Journal of Nuclear Medicine …, 2020 - Springer
In this issue of the EJNMMI, Seban et al.[1] propose a prognostic score combining baseline
total metabolic tumor volume (TMTV) and the Derived Neutrophil-to-Lymphocyte Ratio …
total metabolic tumor volume (TMTV) and the Derived Neutrophil-to-Lymphocyte Ratio …